Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesMRIMRI-based biomarker tool can predict progression to dementiaThe tool measures gray matter shrinkage in the brain, predicting when mild cognitive impairment progresses to dementia.CTIs nitroglycerin necessary prior to photon-counting CT?Molecular ImagingPET outperforms CT in ovarian cancerUltrasoundAdvanced ultrasound techniques improve soft tissue tumor evaluationSponsor ContentNominations Are Open — 2026 Minnies